146 related articles for article (PubMed ID: 6706409)
1. Delta infection among patients with chronic hepatitis B in the Stockholm region.
Lindh G; Weiland O; Hansson BG; Svedmyr A
Infection; 1984; 12(1):27-30. PubMed ID: 6706409
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis B. Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum.
Lindh G
Scand J Infect Dis Suppl; 1986; 50():1-45. PubMed ID: 3468608
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of 60 patients with chronic hepatitis B. I. Seroconversion in the hepatitis B e-system, frequency of delta infection and histological outcome.
Lindh G; Weiland O; Svedmyr A; Glaumann H; Hansson BG
Liver; 1986 Feb; 6(1):7-12. PubMed ID: 3713454
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis.
Govindarajan S; Kanel GC; Peters RL
Gastroenterology; 1983 Jul; 85(1):160-2. PubMed ID: 6852449
[TBL] [Abstract][Full Text] [Related]
5. [Chronic delta-positive hepatitis in childhood].
Calzia R; Navone C; Ciravegna B; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C
G Clin Med; 1984; 65(5-6):250-3. PubMed ID: 6381201
[No Abstract] [Full Text] [Related]
6. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection.
Smedile A; Lavarini C; Crivelli O; Raimondo G; Fassone M; Rizzetto M
J Med Virol; 1982; 9(2):131-8. PubMed ID: 6175733
[TBL] [Abstract][Full Text] [Related]
8. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance and clinical course of chronic delta-positive hepatitis in children (comparison with chronic delta-negative hepatitis in childhood and delta-positive forms in adults)].
Calzia R; Navone C; Ciravegna B; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C
G Clin Med; 1984; 65(5-6):255-60. PubMed ID: 6468807
[No Abstract] [Full Text] [Related]
10. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
[TBL] [Abstract][Full Text] [Related]
11. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
Ponzetto A; Seeff LB; Buskell-Bales Z; Ishak KG; Hoofnagle JH; Zimmerman HJ; Purcell RH; Gerin JL
Hepatology; 1984; 4(6):1111-5. PubMed ID: 6500507
[TBL] [Abstract][Full Text] [Related]
13. Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience.
Shiels MT; Czaja AJ; Taswell HF; Gerin JL; Purcell RH; Ludwig J; Rakela J; Nelson CA
Gastroenterology; 1985 Dec; 89(6):1230-4. PubMed ID: 4054516
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
[No Abstract] [Full Text] [Related]
15. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
[TBL] [Abstract][Full Text] [Related]
16. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
Hansson BG; Moestrup T; Widell A; Nordenfelt E
J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of delta antigen in an American metropolitan population.
Thung SN; Gerber MA
Liver; 1983 Dec; 3(6):392-7. PubMed ID: 6366423
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatitis B viral DNA in sera positive for antibody to delta antigen.
Theilmann L; Gmelin K; Will H; Czygan P; Roggendorf M; Kommerell B
J Infect Dis; 1984 Jul; 150(1):118-20. PubMed ID: 6747341
[TBL] [Abstract][Full Text] [Related]
20. Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.
Chin KP; Govindarajan S; Redeker AG
Dig Dis Sci; 1988 Jul; 33(7):851-6. PubMed ID: 3378478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
